About Careers Internship MedBlog Contact us

Venoms Hold Potential to Fight Cancer, Say Scientists

by Vishnuprasad on August 13, 2014 at 6:43 PM
Font : A-A+

 Venoms Hold Potential to Fight Cancer, Say Scientists

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists find. They have developed a method for targeting venom proteins specifically to malignant cells while sparing healthy ones, which reduces or eliminates side effects that the toxins would otherwise cause.

Dipanjan Pan from the University of Illinois, who led the study, said that they had successfully used venom toxins in tiny nanometer-sized particles to cure breast cancer and melanoma cells in the laboratory.


"These particles, which are camouflaged from the immune system, take the toxin directly to the cancer cells, sparing normal tissue," Pan said.  

Researchers report that these venoms have proteins and peptides that, when separated from the other components and tested individually, can attach to cancer cell membranes. That activity could potentially block the growth and spread of the disease.

The research team says that some of substances found in any of these venoms could be effective anti-tumor agents. However, just injecting venoms into a patient would have side effects. These effects include heart muscle or nerve cells, unwanted clotting or, alternately, bleeding under the skin.

The team set out to solve this problem. In the honeybee study, the team discovered a substance in the venom called melittin that keeps the cancer cells from multiplying.

Bees make so little venom that it's not possible to extract and separate out the substance time after time for lab testing or for later clinical use. That's why they synthesized melittin in the lab.

They carried out computational studies to figure out how melittin would work inside a nanoparticle. They did the test and injected their synthetic toxin into nanoparticles. They explain, "The peptide toxins we made are so tightly packed within the nanoparticle that they don't leach out when exposed to the bloodstream and cause side effects."

What they do is go directly to the tumor, where they bind to cancer stem cells, blocking their growth and spread.  According to the team, the next step is to examine the new treatment approach in rats and pigs. Eventually, they hope to begin a study involving patients. He estimates that this should be in the next three to five years.

Source: Medindia


Recommended Readings

Latest Research News

Is There a Cure for Malaria Through Targeting Biological Clocks?
Malaria parasites sync their molecular rhythms with the internal 24-hour clocks of their hosts, said researchers.
Good Evenings Recovery Leads to Better Work Days
A latest research suggests that the quality of a person's post-work recovery in the evening can impact their mood when they resume work the next day.
Link Between Sleep Apnea and Cognitive Decline
Researchers are working on new strategies and solutions for sleep apnea to ward off a range of health risks including cognitive decline.
Softening Stem Cells Enhances Hair Growth Potential
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
Potential New Strategy for Ischemic Stroke Discovered
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Venoms Hold Potential to Fight Cancer, Say Scientists Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests